Skip to main content
. 2021 May 12;8:670195. doi: 10.3389/fmed.2021.670195

Table 7.

Clinical, laboratory and deaths among COVID-19 ICU patients in Jeddah and Taif.

Variable Jeddah
(n = 208)
Taif
(n = 272)
χ2 P-value
No. % No. %
Fever No 87 41.83 154 56.62 10.31 0.00**
Yes 121 58.17 118 43.38
Cough No 98 47.12 163 59.93 7.79 0.00**
Yes 110 52.88 109 40.07
Shortness of breath No 115 55.29 192 70.59 11.96 0.00**
Yes 93 44.71 80 29.41
Headache and sore throat No 184 88.46 243 89.34 0.09 0.76
Yes 24 11.54 29 10.66
Smell No 197 94.70 252 92.60 0.83 0.36
Yes 11 5.30 20 7.40
Loss of Taste No 203 97.60 271 99.63 3.96 0.04*
Yes 5 2.40 1 0.37
GIT symptoms No 181 87.02 233 85.7 0.183 0.669
Yes 27 12.98 39 14.3
Chronic diseases No 175 84.13 238 87.5 1.11 0.29
Yes 33 15.87 34 12.5
Diabetes mellites No 162 77.88 219 80.5 0.498 0.48
Yes 46 22.12 53 19.5
Hypertension No 169 81.20 225 82.70 0.17 0.67
Yes 39 18.80 47 17.30
Asthma No 194 93.30 251 92.30 0.17 0.67
Yes 14 6.70 21 7.70
DVT No 205 98.60 256 94.10 6.11 0.01 *
Yes 3 1.40 16 5.90
PE No 205 98.60 244 89.70 15.28 0.00**
Yes 3 1.40 28 10.30
MI No 206 99.00 259 95.20 5.67 0.01*
Yes 2 1.00 13 4.80
Ischemic stroke No 202 97.10 259 95.20 1.11 0.29
Yes 6 2.90 13 4.80
ARDS No 186 89.42 258 94.85 5 0.02*
Yes 22 10.58 14 5.15
Acute large vessels occlusion No 207 99.52 259 95.22 7.69 0.00**
Yes 1 0.48 13 4.78
Coronary disease No 203 97.60 260 95.59 1.39 0.23
Yes 5 2.40 12 4.41
Tumor No 205 98.56 272 205 3.94 0.04*
Yes 3 1.44 0 0
CKD No 203 97.60 270 99.26 2.28 0.13
Yes 5 2.40 2 0.74
Death No 30 14.42 13 4.78 11.37 0.00**
Yes 178 85.58 259 95.22
*

P-value refers to statistically significant result.

**

P-value refers to statistically highly significant result.